Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36952359)

  • 1. Differences in clinical characteristics and prognosis between breast neuroendocrine carcinoma and breast invasive ductal carcinoma: A multicentre population-based study from China.
    Wang DY; Li SF; Gao SL; Yuan P; Zhang BL
    Cancer Med; 2023 Apr; 12(8):9644-9649. PubMed ID: 36952359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
    Zhao H
    Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
    Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
    BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
    Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
    Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-quality model for predicting the prognosis of breast neuroendocrine carcinoma to help clinicians decide on appropriate treatment methods: A population-based analysis.
    Chen YQ; Xu XF; Xu JW; Di TY; Wang XL; Huo LQ; Wang L; Gu J; Zhou GH
    Transl Oncol; 2022 Aug; 22():101467. PubMed ID: 35700595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
    Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
    Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive micropapillary carcinoma of the breast had no difference in prognosis compared with invasive ductal carcinoma: a propensity-matched analysis.
    Hao S; Zhao YY; Peng JJ; Ren F; Yang WT; Yu KD; Shao ZM
    Sci Rep; 2019 Jan; 9(1):286. PubMed ID: 30670771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in the breast: a meta-analysis.
    Wu Y; Zhang N; Yang Q
    BMC Cancer; 2017 Dec; 17(1):839. PubMed ID: 29228910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic Characteristics and Prognosis of Invasive Papillary Carcinoma of the Breast.
    Huang K; Appiah L; Mishra A; Bagaria SP; Gabriel ME; Misra S
    J Surg Res; 2021 May; 261():105-112. PubMed ID: 33422900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified.
    Cao AY; He M; Huang L; Shao ZM; Di GH
    World J Surg Oncol; 2013 Apr; 11():91. PubMed ID: 23607710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar outcomes between adenoid cystic carcinoma of the breast and invasive ductal carcinoma: a population-based study from the SEER 18 database.
    Chen QX; Li JJ; Wang XX; Lin PY; Zhang J; Song CG; Shao ZM
    Oncotarget; 2017 Jan; 8(4):6206-6215. PubMed ID: 28008158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive micropapillary carcinoma of the breast had poor clinical characteristics but showed no difference in prognosis compared with invasive ductal carcinoma.
    Li G; Yang S; Yao J; Wang Z; Yao G; Liu M; Ye C
    World J Surg Oncol; 2016 Aug; 14(1):207. PubMed ID: 27492008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The comparison of characters between invasive micropapillary carcinoma and invasive ductal carcinoma not otherwise specified of the breast].
    Hua B; Lu X; Xiao WZ; He SR; Wang Z
    Zhonghua Wai Ke Za Zhi; 2017 Oct; 55(10):770-774. PubMed ID: 29050179
    [No Abstract]   [Full Text] [Related]  

  • 14. The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients.
    Bae SY; Lee SK; Koo MY; Hur SM; Choi MY; Cho DH; Kim S; Choe JH; Lee JE; Kim JH; Kim JS; Nam SJ; Yang JH
    Breast Cancer Res Treat; 2011 Apr; 126(2):471-8. PubMed ID: 21287362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature.
    Angarita FA; Rodríguez JL; Meek E; Sánchez JO; Tawil M; Torregrosa L
    World J Surg Oncol; 2013 Jun; 11():128. PubMed ID: 23734899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of prognostic significance of the proposed uniform classification framework in neuroendocrine neoplasms of the breast.
    Yang L; Roy M; Lin H; Shen Y; Albarracin C; Huo L; Chen H; Wei B; Bedrosian I; Bu H; Wu Y
    Breast Cancer Res Treat; 2021 Apr; 186(2):403-415. PubMed ID: 33528758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome and therapeutic impact on neuroendocrine neoplasms of the breast: a national cancer database study.
    Yang L; Lin H; Shen Y; Roy M; Albarracin C; Ding Q; Huo L; Chen H; Wei B; Bu H; Bedrosian I; Wu Y
    Breast Cancer Res Treat; 2023 Nov; 202(1):23-32. PubMed ID: 37566192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does concomitant ductal carcinoma in situ affect the clinical outcome in breast cancer patients with invasive ductal carcinoma: An Asian perspective.
    Lee WP; Shetty SS; Seah CMJ; Tan PT; Tan SM
    Cancer Rep (Hoboken); 2022 Sep; 5(9):e1646. PubMed ID: 35892151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of ductal carcinoma in situ on the outcome of invasive breast cancer. A prospective cohort study.
    Lopez Gordo S; Blanch Falp J; Lopez-Gordo E; Just Roig E; Encinas Mendez J; Seco Calvo J
    Int J Surg; 2019 Mar; 63():98-106. PubMed ID: 30738200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinicopathological characteristics and prognosis among patients with pure invasive ductal carcinoma, invasive ductal carcinoma coexisted with invasive micropapillary carcinoma, and invasive ductal carcinoma coexisted with ductal carcinoma in situ: A retrospective cohort study.
    Guan X; Xu G; Shi A; Zou Y; Zhan Y; Fan Z; Dong Y
    Medicine (Baltimore); 2020 Dec; 99(50):e23487. PubMed ID: 33327281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.